As the Novartis Group (Novartis Pharmaceuticals, Novartis Oncology and Sandoz), we have been discovering new ways to improve the quality of life, extend the life of our people and contribute to the development of Turkish medicine. Through our manufacturing sites in Turkey, we aim to export selected innovative products from Turkey while continuing research and development activities for unmet medical needs. We create added-value to the Turkish economy with USD 1.5 billion pharma exports for more than a decade and together with our approx. 2,400 employees. As one of the largest pharmaceutical companies globally, we aim to ensure the continuity of our assets and future investments in Turkey.